Michael J. Garabedian
- NYU Grossman School of Medicine · Microbiology & Immunology (NIH department code)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
FY2024 NIH rank #14,270
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1926012Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Microbiology & Immunology
NIH Funding · FY2024
Linked Award Amount
$1M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#14,270
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Michael J. Garabedian as a PI. Multi-PI records show the full award amount for context.
- 1R01CA276438-01A1R01Contact PIPeptoid conjugates targeting prostate cancerNYU Grossman School of Medicine · Microbiology & Immunology (NIH department code)$624Kaward amount
- 5R21AI176657-02R21Contact PI“Protection from MRSA lethality by inhibiting LXRα phosphorylation”NYU Grossman School of Medicine · Microbiology & Immunology (NIH department code)$211.9Kaward amount
- 5R21DC021054-02R21Contact PIMolecular mechanisms underlying optimal glucocorticoid therapy for vocal fold diseaseNYU Grossman School of Medicine · Microbiology & Immunology (NIH department code)$211.9Kaward amount
Award organization
Organizations that administered FY2024 awards listing Michael J. Garabedian as a PI.
FY2024 award administered by NYU Grossman School of Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardNYU Grossman School of Medicine
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding
- 2026Entered Top 50% NationallyRanked #7531
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Michael J. Garabedian.